Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β Pathway in streptozotocin-induced alzheimer rat model

Brain Pathology

Volumn 24, Issue 3, 2014, Pages 261-269

  Gao, Chong ^a   Liu, Yueze ^a   Jiang, Yuanhong ^a   Ding, Jianming ^b   Li, Lin ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; geniposide; glucagon like peptide 1 receptor; glycogen synthase kinase 3 ; tau hyperphosphorylation; type 2 diabetes

Indexed keywords

GENIPOSIDE; GLYCOGEN SYNTHASE KINASE 3BETA; STREPTOZOCIN; TAU PROTEIN; ANTINEOPLASTIC ANTIBIOTIC; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; IRIDOID;

ADULT; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN VENTRICLE; DRUG EFFECT; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ENZYME INHIBITION; LEARNING DISORDER; MALE; MEMORY DISORDER; MORRIS WATER MAZE TEST; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SPATIAL LEARNING; ULTRASTRUCTURE; ANIMAL; CELL VACUOLE; CHEMICALLY INDUCED; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; MAZE TEST; MEMORY DISORDERS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TOXICITY; TRANSMISSION ELECTRON MICROSCOPY;

ALZHEIMER DISEASE; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; DISEASE MODELS, ANIMAL; GLYCOGEN SYNTHASE KINASE 3; HIPPOCAMPUS; IRIDOIDS; MALE; MAZE LEARNING; MEMORY DISORDERS; MICROSCOPY, ELECTRON, TRANSMISSION; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STREPTOZOCIN; TAU PROTEINS; VACUOLES;

EID: 84898542999     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12116     Document Type: Article

References (46)

1. Agrawal R, Tyagi E, Shukla R, Nath C, (2011) Insulin receptor signaling in rat hippocampus: a study in STZ (ICV) induced memory deficit model. Eur Neuropsychopharmacol 21: 261-273.
2. Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB, (2011) Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol 71: 365-376.
3. Atri A, (2011) Effective pharmacological management of Alzheimer's disease. Am J Manag Care 17: S346-355.
4. Campion D, Dumanchin C, Hannequin D, Dubois B, Belliard S, Puel M, et al (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65: 664-670.
5. Carvalho C, Cardoso S, Correia SC, Santos RX, Santos MS, Baldeiras I, et al (2012) Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities. Diabetes 61: 1234-1242.
6. Cornish TC, Halushka MK, (2009) Color deconvolution for the analysis of tissue microarrays. Anal Quant Cytol Histol 31: 304-312.
7. Dhull DK, Jindal A, Dhull RK, Aggarwal S, Bhateja D, Padi SS, (2012) Neuroprotective effect of cyclooxygenase inhibitors in ICV-STZ induced sporadic alzheimer's disease in rats. J Mol Neurosci 46: 223-235.
8. Dikranian K, Kim J, Stewart FR, Levy MA, Holtzman DM, (2012) Ultrastructural studies in APP/PS1 mice expressing human ApoE isoforms: implications for Alzheimer's disease. Int J Clin Exp Pathol 5: 482-495.
9. Duan Y, Dong S, Gu F, Hu Y, Zhao Z, (2012) Advances in the pathogenesis of Alzheimer's disease: focusing on tau-mediated neurodegeneration. Transl Neurodegener 1: 24.
10. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100: 4162-4167.
11. Frolich L, Blum-Degen D, Bernstein HG, Engelsberger S, Humrich J, Laufer S, et al (1998) Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 105: 423-438.
12. Gao C, Holscher C, Liu Y, Li L, (2012) GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev Neurosci 23: 1-11.
13. Hernandez F, Nido JD, Avila J, Villanueva N, (2009) GSK3 inhibitors and disease. Mini Rev Med Chem 9: 1024-1029.
14. Holscher C, (2011) Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease. Biochem Soc Trans 39: 891-897.
15. Hou YC, Tsai SY, Lai PY, Chen YS, Chao PD, (2008) Metabolism and pharmacokinetics of genipin and geniposide in rats. Food Chem Toxicol 46: 2764-2769.
16. Hu S, Begum AN, Jones MR, Oh MS, Beech WK, Beech BH, et al (2009) GSK3 inhibitors show benefits in an Alzheimer's disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiol Dis 33: 193-206.
17. Huang CY, Hsiao JK, Lu YZ, Lee TC, Yu LC, (2011) Anti-apoptotic PI3K/Akt signaling by sodium/glucose transporter 1 reduces epithelial barrier damage and bacterial translocation in intestinal ischemia. Lab Invest 91: 294-309.
18. Isik AT, Celik T, Ulusoy G, Ongoru O, Elibol B, Doruk H, et al (2009) Curcumin ameliorates impaired insulin/IGF signalling and memory deficit in a streptozotocin-treated rat model. Age (Dordr) 31: 39-49.
19. Joyal JL, Burks DJ, Pons S, Matter WF, Vlahos CJ, White MF, Sacks DB, (1997) Calmodulin activates phosphatidylinositol 3-kinase. J Biol Chem 272: 28183-28186.
20. Lee J, Kim MS, (2007) The role of GSK3 in glucose homeostasis and the development of insulin resistance. Diabetes Res Clin Pract 77: S49-57.
21. Li L, Holscher C, (2007) Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev 56: 384-402.
22. Li L, Zhang ZF, Holscher C, Gao C, Jiang YH, Liu YZ, (2012) (Val(8)) glucagon-like peptide-1 prevents tau hyperphosphorylation, impairment of spatial learning and ultra-structural cellular damage induced by streptozotocin in rat brains. Eur J Pharmacol 674: 280-286.
23. Ling ZQ, Tian Q, Wang L, Fu ZQ, Wang XC, Wang Q, Wang JZ, (2009) Constant illumination induces Alzheimer-like damages with endoplasmic reticulum involvement and the protection of melatonin. J Alzheimers Dis 16: 287-300.
24. Liu J, Zheng X, Yin F, Hu Y, Guo L, Deng X, et al (2006) Neurotrophic property of geniposide for inducing the neuronal differentiation of PC12 cells. Int J Dev Neurosci 24: 419-424.
25. Liu JH, Yin F, Guo LX, Deng XH, Hu YH, (2009) Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway. Acta Pharmacol Sin 30: 159-165.
26. Liu J, Yin F, Xiao H, Guo L, Gao X,. (2012) Glucagon-like peptide 1 receptor plays an essential role in geniposide attenuating lipotoxicity-induced β-cell apoptosis. Toxicol In Vitro 26: 1093-1097
27. Long J, He P, Shen Y, Li R, (2012) New evidence of mitochondria dysfunction in the female Alzheimer's disease brain: deficiency of estrogen receptor-beta. J Alzheimers Dis 30: 545-558.
28. Lu TS, Yiao SY, Lim K, Jensen RV, Hsiao LL, (2010) Interpretation of biological and mechanical variations between the Lowry versus Bradford method for protein quantification. N Am J Med Sci 2: 325-328.
29. Luchsinger JA, Tang MX, Shea S, Mayeux R, (2004) Hyperinsulinemia and risk of Alzheimer disease. Neurology 63: 1187-1192.
30. Luchsinger JA, Tang MX, Stern Y, Shea S, Mayeux R, (2001) Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 154: 635-641.
31. McClean PL, Parthsarathy V, Faivre E, Holscher C, (2011) The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease. J Neurosci 31: 6587-6594.
32. Morris R, (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60.
33. Obulesu M, Venu R, Somashekhar R, (2011) Tau mediated neurodegeneration: an insight into Alzheimer's disease pathology. Neurochem Res 36: 1329-1335.
34. Parthsarathy V, Holscher C, (2013) Chronic treatment with the GLP1 analogue liraglutide increases cell proliferation and differentiation into neurons in an AD mouse model. PLoS One 8: e58784.
35. Peineau S, Taghibiglou C, Bradley C, Wong TP, Liu L, Lu J, et al (2007) LTP inhibits LTD in the hippocampus via regulation of GSK3beta. Neuron 53: 703-717.
36. Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M, Riederer P, Hoyer S, (2010) Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. J Alzheimers Dis 19: 691-704.
37. Plaschke K, Muller D, Hoyer S, (2010) Insulin-resistant brain state (IRBS) changes membrane composition of fatty acids in temporal and entorhinal brain cortices of rats: relevance to sporadic Alzheimer's disease? J Neural Transm 117: 1419-1422.
38. Ponce-Lopez T, Liy-Salmeron G, Hong E, Meneses A, (2011) Lithium, phenserine, memantine and pioglitazone reverse memory deficit and restore phospho-GSK3beta decreased in hippocampus in intracerebroventricular streptozotocin induced memory deficit model. Brain Res 1426: 73-85.
39. Pouryamout L, Dams J, Wasem J, Dodel R, Neumann A, (2012) Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses. Drugs 72: 789-802.
40. Repas T, (2011) Next-generation GLP-1 therapy: an introduction to liraglutide. Postgrad Med 123: 239-247.
41. Ruben GC, Wang JZ, Iqbal K, Grundke-Iqbal I, (2005) Paired helical filaments (PHFs) are a family of single filament structures with a common helical turn period: negatively stained PHF imaged by TEM and measured before and after sonication, deglycosylation, and dephosphorylation. Microsc Res Tech 67: 175-195.
42. Rudrabhatla P, Jaffe H, Pant HC, (2011) Direct evidence of phosphorylated neuronal intermediate filament proteins in neurofibrillary tangles (NFTs): phosphoproteomics of Alzheimer's NFTs. FASEB J 25: 3896-3905.
43. Salkovic-Petrisic M, Hoyer S, (2007) Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach. J Neural Transm Suppl 1: 217-233.
44. van den Bosch de Aguilar P, Goemaere-Vanneste J, (1984) Paired helical filaments in spinal ganglion neurons of elderly rats. Virchows Arch B Cell Pathol Incl Mol Pathol 47: 217-222.
45. Woodgett JR, (1991) cDNA cloning and properties of glycogen synthase kinase-3. Methods Enzymol 200: 564-577.
46. Woodgett JR, Cohen P, (1984) Multisite phosphorylation of glycogen synthase. Molecular basis for the substrate specificity of glycogen synthase kinase-3 and casein kinase-II (glycogen synthase kinase-5). Biochim Biophys Acta 788: 339-347.